TLX591-CDx (Illuccix® in approved jurisdictions, 68 Ga-PSMA-11 ): Positive data from Phase 3 study in Chinese patients provides the basis for near-term NDA submission in China.
18h
My Fiancé Gave Me An Incredible Gift To Help Get Me Out Of Debt. Then I Did The Unthinkable With It.
It was a test, one I had to pass — for the sake of both my relationship and my own self-respect. But I failed.” ...
Eric Pōmaikaʻi Gee, a University of Hawaiʻi at Mānoa sophomore, Waikōloa native and graduate of Kealakehe High School on the ...
Scared Of on MSN
Abandoned places so haunted even experts stay away, data shows
The Fort That Bans Visitors After Dark Bhangarh Fort is officially prohibited to enter after sunset and before sunrise, with ...
The 69-year-old Orillia cyclist had just completed what few people ever attempt, a 30,000-kilometre bicycle ride around the ...
Precision Medicine Portfolio Update: Illuccix China Phase 3 Study, TLX101-CDx and TLX250-CDx FDA Res
MELBOURNE, Australia and INDIANAPOLIS, Dec. 22, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, ...
Stephen Hawking offered a profound perspective on humanitys place in the universe, highlighting a striking paradox: physically, we are tiny beings on an ordinary planet, yet our minds give us the ...
Ann Behan has 10 years-plus of experience researching, writing, and editing articles, white papers, and executing searches at the board level across various industries. Her expertise includes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback